L'Oreal is moving to address skin changes tied to rapid weight loss as GLP-1 medications become more widely used, the company signaled while reporting stronger quarterly sales on Thursday.
Sales rose 7.7% in the three months through September, surpassing analyst expectations.
Chief Executive Nicolas Hieronimus said the beauty market has stayed resilient despite difficult global economic conditions, and he pointed to GLP-1 medications as a growing force for the industry.
On an investor call, he called the expanding use of the drugs "a very important phenomenon for us".
Hieronimus linked the trend to shifting purchasing behavior, saying the medications were "having an impact on beauty consumption and skin care consumption in particular".
Brands Built Around Weight-Loss Skin Concerns
GLP-1 drugs gained popularity after medicines first developed for diabetes were found to produce substantial weight loss by suppressing appetite.
Products such as Ozempic, Wegovy and Mounjaro have driven interest in the treatment category.
Rapid weight loss can leave some people with loose skin, including around the face, an effect tied to the speed and extent of the loss rather than to the medications directly.
L'Oreal is responding through brands including SkinCeuticals and Kiehl's, which offer products aimed at skin concerns linked to major weight changes.
Hieronimus said the products were designed "to work alongside and complement GLP-1 and its side effects on skin sagging".
The company has also deepened its presence in clinical aesthetics, a market centered on treatments meant to improve physical appearance.
In December 2025, L'Oreal raised its stake in dermatology company Galderma to 20%.
According to Reuters, L'Oreal and Galderma have separately run clinical trials involving GLP-1 users concerned about loose skin.
Galderma owns aesthetic products including Sculptra, an injectable designed to stimulate collagen production, and Restylane, an injectable dermal filler.
Last year, Galderma published a report on rising GLP-1 use and concerns about facial appearance changes.
Its survey of people using weight loss medications found that the vast majority had noticed changes to their facial appearance after taking the drugs.
